BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Mountain Standard Time BEGIN:STANDARD DTSTART:20231102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Mountain Standard Time TZOFFSETFROM:-0600 TZOFFSETTO:-0700 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Mountain Daylight Time TZOFFSETFROM:-0700 TZOFFSETTO:-0600 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION: \;Faculty: \;Elizabeth R. Volkmann\, MD\, MSAssistant Professor of MedicineDirector\, UCLA Scleroderma ProgramCo-Director\, UCLA CTD-ILD ProgramDivision of RheumatologyDepartment of MedicineUniversity o f California\, Los Angeles \;David Geffen School of MedicineLos Angele s\, CADescription: \;After completing this activity\, the participant should be better able to:Assess patient risk factors for progressive SSc-I LDDescribe recommended monitoring for patients with scleroderma and SSc-IL DDevelop appropriate\, evidence-based treatment plans for patients who hav e SSc-ILDSummarize data on emerging agents for the treatment of SSc-ILDThi s activity is provided by Paradigm Medical Communications\, LLC.This activ ity is held in collaboration with the Interstitial Lung Disease Program at the University of Arizona and the Pulmonary Fibrosis Foundation.Register Today \; DTEND:20211012T204500Z DTSTAMP:20240329T133557Z DTSTART:20211012T194500Z LOCATION:Virtual SEQUENCE:0 SUMMARY:New Directions Targeting Inflammatory and Fibrotic Pathways in the Management of SSc-ILD UID:RFCALITEM638472981578417629 X-ALT-DESC;FMTTYPE=text/html:
 \;
Faculty: \;
Elizabeth R. Volkmann\, MD\, MS
Assistant Pr
ofessor of Medicine
Director\, UCLA Scleroderma Program
Co-Director\
, UCLA CTD-ILD Program
Division of Rheumatology
Department of Medici
ne
University of California\, Los Angeles \;
David Geffen School
of Medicine
Los Angeles\, CA
Description: \;
After compl eting this activity\, the participant should be better able to:
This activity is provided by Paradigm Medical Co mmunications\, LLC.
This activity is held in collaboration with the Interstitial Lung Disease Program at the University of Ar izona and the Pulmonary Fibrosis Foundation.
 \;